| ForeignExchange's telephone seminars address issues around regulatory compliance, translation, and technology. | |
 |
|
 |
|
| Multilingual Compliance Audio Conferences | |
|
|
| White papers | |
|
|
| Presentations | |
|
|
| Industry resources | |
|
|
| Globalization and localization | |
|
|
| Language resources | |
|
|
 |
|
|
Audio Conference | ||
|
|
||
Register for this Audio Conference The greatest issue in accruing patients to oncology clinical trials today is the overwhelming number of open protocols and associated workload at the established clinical research sites in the US. The known research sites are constantly approached by every Sponsor and CRO to participate in the next trial. Many sites have over 50 protocols open at any given time and only accrue to about 10 of them. This results in many trials lagging behind, which ultimately means delayed development of new drugs. There remain many sites in the US and elsewhere with patients that would benefit from new treatments being tested, but they do not have the internal resources to conduct trials according to Good Clinical Practices. There are several steps that should be taken to develop a high quality clinical research program in a practice or hospital to assure adherence to FDA guidelines. Now more than ever, developing research sites are in a great position to build an excellent program in their location, as Sponsors and CROs are on the lookout for these desperately needed new sites to complement the tried and true. This presentation will focus on how to methodically develop a research program that fits in with your current practice workflow and patients. This audio conference will address:
Speaker biography: Kerrie Cottrell has over 20 years of experience in clinical oncology research. Her first fifteen years were spent as a Clinical Research Coordinator in both academic and community-based settings. The last ten years have been dedicated to the building and management of national oncology clinical trial programs with community-based oncologists. She has developed successful programs in over thirty research-naïve practices by identifying and implementing studies that meet the needs of the patients and the practices. Prior to joining PRA, she led Clinical Development in collaboration with the physician leadership at US Oncology. Who should attend?
|
